Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Hypersensitivity Reaction

  Free Subscription


Articles published in Respir Med

Retrieve available abstracts of 80 articles:
HTML format



Single Articles


    November 2022
  1. SANSORES RH, Paulin-Prado P, Robles-Hernandez R, Montiel-Lopez F, et al
    Clinical and microbiological characteristics and inflammatory profile during an exacerbation of COPD due to biomass exposure. A comparison with COPD due to tobacco exposure.
    Respir Med. 2022;204:107010.
    PubMed     Abstract available


    October 2022
  2. CHAN KC, Au CT, Wong E, Chook P, et al
    Inferior endothelial function improved following optimisation of asthma control in children.
    Respir Med. 2022;204:107024.
    PubMed     Abstract available


  3. TOOBA R, Wu TD
    Obesity and asthma: A focused review.
    Respir Med. 2022;204:107012.
    PubMed    


  4. CABALLERO-SEGURA FJ, Lopez-de-Andres A, Jimenez-Garcia R, de Miguel-Yanes JM, et al
    Trends in asthma hospitalizations among adults in Spain: Analysis of hospital discharge data from 2011 to 2020.
    Respir Med. 2022;204:107009.
    PubMed     Abstract available


  5. GHOSH S, Rihan M, Ahmed S, Pande AH, et al
    Immunomodulatory potential of apolipoproteins and their mimetic peptides in asthma: Current perspective.
    Respir Med. 2022;204:107007.
    PubMed     Abstract available


    September 2022
  6. MANEECHOTESUWAN K, Singh D, Fritscher LG, Dursunoglu N, et al
    Impact of inhaled fluticasone propionate/salmeterol on health-related quality of life in asthma: A network meta-analysis.
    Respir Med. 2022;203:106993.
    PubMed     Abstract available


  7. TRAN C, Singh GV, Haider E, Boylan C, et al
    Luminal mucus plugs are spatially associated with airway wall thickening in severe COPD and asthma: A single-centered, retrospective, observational study.
    Respir Med. 2022;202:106982.
    PubMed     Abstract available


  8. ROCHE N, Aggarwal B, Boucot I, Mittal L, et al
    The impact of inhaler technique on clinical outcomes in adolescents and adults with asthma: A systematic review.
    Respir Med. 2022;202:106949.
    PubMed     Abstract available


    August 2022
  9. BOURDIN A, Virchow JC, Papi A, Lugogo NL, et al
    Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline.
    Respir Med. 2022;202:106938.
    PubMed     Abstract available


  10. TAJIRI S, Kondo T, Tanigaki T, Hibino M, et al
    Daily inhaled flow profiles and drug release from dry powder inhalers in patients with bronchial asthma.
    Respir Med. 2022;201:106950.
    PubMed     Abstract available


  11. CHAPMAN KR, Canonica GW, Lavoie KL, Nenasheva N, et al
    Patients' and physicians' perspectives on the burden and management of asthma: Results from the APPaRENT 2 study.
    Respir Med. 2022;201:106948.
    PubMed     Abstract available


  12. CANONICA GW, Spanevello A, de Llano LP, Domingo Ribas C, et al
    Is asthma control more than just an absence of symptoms? An expert consensus statement.
    Respir Med. 2022;202:106942.
    PubMed     Abstract available


  13. TRELA KC, Zajac P, Zhu M, Press VG, et al
    Health literacy and type of education intervention predicting post-education metered-dose inhaler misuse.
    Respir Med. 2022;200:106930.
    PubMed     Abstract available


    July 2022
  14. LI M, Wen Ma Z, Jun Deng S, Oliver BG, et al
    Development and validation of a noninvasive prediction model for identifying eosinophilic asthma.
    Respir Med. 2022;201:106935.
    PubMed     Abstract available


  15. ORLOVIC M, Magni T, Lukyanov V, Guerra I, et al
    Cost-effectiveness of single-inhaler extrafine beclometasone dipropionate/formoterol fumarate/glycopyrronium in patients with uncontrolled asthma in England.
    Respir Med. 2022;201:106934.
    PubMed     Abstract available


  16. HENRY SL, Moore LE, Brotto AR, Rowland S, et al
    Systemic vascular health is compromised in both confirmed and unconfirmed asthma.
    Respir Med. 2022;200:106932.
    PubMed     Abstract available


  17. ALHABEEB FF, Whitmore GA, Vandemheen KL, FitzGerald JM, et al
    Disease burden in individuals with symptomatic undiagnosed asthma or COPD.
    Respir Med. 2022;200:106917.
    PubMed     Abstract available


    June 2022
  18. PATELLA V, Pelaia C, Zunno R, Pelaia G, et al
    Biologicals decrease psychological distress, anxiety and depression in severe asthma, despite Covid-19 pandemic.
    Respir Med. 2022;200:106916.
    PubMed     Abstract available


  19. LIU L, Zhang X, Zhang L, Liu Y, et al
    Reduced bronchodilator reversibility correlates with non-type 2 high asthma and future exacerbations: A prospective cohort study.
    Respir Med. 2022;200:106924.
    PubMed     Abstract available


  20. HUGHES R, Rapsomaniki E, Janson C, Keen C, et al
    Frequent productive cough: Symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study.
    Respir Med. 2022;200:106921.
    PubMed     Abstract available


  21. CAZZOLA M, Braido F, Calzetta L, Matera MG, et al
    The 5T approach in asthma: Triple Therapy Targeting Treatable Traits.
    Respir Med. 2022;200:106915.
    PubMed     Abstract available


  22. LEONARD SI, Turi ER, Powell JS, Usseglio J, et al
    Associations of asthma self-management and mental health in adolescents: A scoping review.
    Respir Med. 2022;200:106897.
    PubMed     Abstract available


    May 2022
  23. SON JH, Park JS, Lee JU, Kim MK, et al
    A genome-wide association study on frequent exacerbation of asthma depending on smoking status.
    Respir Med. 2022 May 17:106877. doi: 10.1016/j.rmed.2022.106877.
    PubMed     Abstract available


  24. IKWU I, Nicolas LG, Mehari A, Gillum RF, et al
    Fractional exhaled nitric oxide and mortality in asthma and chronic obstructive pulmonary disease in a national cohort aged 40 years and older.
    Respir Med. 2022 May 16:106879. doi: 10.1016/j.rmed.2022.106879.
    PubMed     Abstract available


  25. JIAO T, Schnitzer ME, Forget A, Blais L, et al
    Identifying asthma patients at high risk of exacerbation in a routine visit: A machine learning model.
    Respir Med. 2022;198:106866.
    PubMed     Abstract available


  26. GOLAM SM, Janson C, Beasley R, FitzGerald JM, et al
    The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study.
    Respir Med. 2022;200:106863.
    PubMed     Abstract available


    April 2022
  27. TOUKAN N, Kulnik ST, Lewko A, ElShaer A, et al
    Therapeutic applications of capsaicin in humans to target conditions of the respiratory system: A scoping review.
    Respir Med. 2022;194:106772.
    PubMed     Abstract available


    February 2022
  28. BENDIEN SA, van Leeuwen MM, Lau HS, Ten Brinke A, et al
    Home-based intravenous treatment with reslizumab for severe asthma in the Netherlands - An evaluation.
    Respir Med. 2022 Feb 23:106776. doi: 10.1016/j.rmed.2022.106776.
    PubMed     Abstract available


  29. AL-AHMAD M, Webb D
    A prospective study of switching asthma patients from a Fixed-Dose Combination (FDC) Inhaled Corticosteroid [ICS]/Long-Acting Beta Agonist [LABA] therapy delivered by Dry Powder Inhaler (DPI) to ICS/LABA delivered by pressurised Metered Dose Inhaler (
    Respir Med. 2022;194:106771.
    PubMed     Abstract available


    January 2022
  30. JI Z, Lopez-de-Andres A, Jimenez-Garcia R, Maestre-Miquel C, et al
    Mental health in patients with asthma: A population-based case-control study.
    Respir Med. 2022;193:106758.
    PubMed     Abstract available


  31. VRSALOVIC R, Korosec P, Stefanovic IM, Bidovec-Stojkovic U, et al
    Value of thymic stromal lymphopoietin as a biomarker in children with asthma.
    Respir Med. 2022;193:106757.
    PubMed     Abstract available


  32. SLOVARP L, Reynolds JE, Bozarth-Dailey E, Popp S, et al
    Cough desensitization treatment: A randomized, sham-controlled pilot trial for patients with refractory chronic cough.
    Respir Med. 2022;193:106739.
    PubMed     Abstract available


  33. BOURDIN A, Molinari N
    Non-optimal methodology questions indirect treatment comparison of dupilumab vs. other biologics in severe asthma.
    Respir Med. 2022;191:105999.
    PubMed    


  34. BATEMAN ED, Khan AH, Xu Y, Guyot P, et al
    Response to the correspondence: "Non-optimal methodology questions indirect treatment comparison of dupilumab vs other biologics in severe asthma".
    Respir Med. 2022;191:106088.
    PubMed    


  35. MARTIN N, Papi A, Bratton DJ, Chan R, et al
    Comment on: Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma [Respir Med 2020].
    Respir Med. 2022;191:106065.
    PubMed    


  36. BATEMAN ED, Khan AH, Xu Y, Guyot P, et al
    Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma.
    Respir Med. 2022;191:105991.
    PubMed     Abstract available


  37. PIRNER C, Korbely C, Heinze S, Huss J, et al
    Atopic diseases and airway-related symptoms in Bavarian children before starting primary school: Time trend analyses.
    Respir Med. 2022;191:106707.
    PubMed     Abstract available


  38. BATEMAN ED, Khan AH, Xu Y, Guyot P, et al
    Response to comment on: Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma (Respir. Med. 2020).
    Respir Med. 2022;191:106106.
    PubMed    


    December 2021
  39. MONTEIRO C, Maricoto T, Prazeres F, Augusto Simoes P, et al
    Determining factors associated with inhaled therapy adherence on asthma and COPD: A systematic review and meta-analysis of the global literature.
    Respir Med. 2021;191:106724.
    PubMed     Abstract available


  40. PENG J, Wu F, Tian H, Yang H, et al
    Clinical characteristics of and risk factors for small airway dysfunction detected by impulse oscillometry.
    Respir Med. 2021;190:106681.
    PubMed     Abstract available


    November 2021
  41. FAN Q, Ong ASE, Koh MS, Doshi K, et al
    The mediating role of trust in physician and self-efficacy in understanding medication adherence in severe asthma.
    Respir Med. 2021;190:106673.
    PubMed     Abstract available


  42. ZAIGHAM S, Zhou X, Molin M, Sjolander A, et al
    Importance of type and degree of IgE sensitisation for defining fractional exhaled nitric oxide reference values.
    Respir Med. 2021;188:106621.
    PubMed     Abstract available


    October 2021
  43. CZIRA A, Turner M, Martin A, Hinds D, et al
    A systematic literature review of burden of illness in adults with uncontrolled moderate/severe asthma.
    Respir Med. 2021;191:106670.
    PubMed     Abstract available


  44. ROGLIANI P, Ritondo BL, Puxeddu E, Cazzola M, et al
    Impact of long-acting muscarinic antagonists on small airways in asthma and COPD: A systematic review.
    Respir Med. 2021;189:106639.
    PubMed     Abstract available


  45. RODRIGUEZ-GARCIA C, Blanco-Aparicio M, Nieto-Fontarigo JJ, Blanco-Cid N, et al
    Efficacy of mepolizumab in usual clinical practice and characteristics of responders.
    Respir Med. 2021;187:106595.
    PubMed     Abstract available


  46. AGUSTI A, Barnes N, Cruz AA, Gibson PG, et al
    Moving towards a Treatable Traits model of care for the management of obstructive airways diseases.
    Respir Med. 2021;187:106572.
    PubMed     Abstract available


  47. RIIKONEN R, Korppi M, Tormanen S, Koponen P, et al
    Risk factors for irreversible airway obstruction after infant bronchiolitis.
    Respir Med. 2021;187:106545.
    PubMed     Abstract available


    September 2021
  48. DE BOER GM, Tramper-Stranders GA, Houweling L, van Zelst CM, et al
    Adult but not childhood onset asthma is associated with the metabolic syndrome, independent from body mass index.
    Respir Med. 2021;188:106603.
    PubMed     Abstract available


  49. ROGLIANI P, Beasley R, Cazzola M, Calzetta L, et al
    SMART for the treatment of asthma: A network meta-analysis of real-world evidence.
    Respir Med. 2021;188:106611.
    PubMed     Abstract available


  50. CHU LM, Rennie DC, Kirychuk S, Cockcroft DW, et al
    Atopy risk among school-aged children in relation to early exposures to a farm environment: A systematic review.
    Respir Med. 2021;186:106378.
    PubMed     Abstract available


    August 2021
  51. AL-AHMAD M, Nurkic J, Othman Y, Jusufovic E, et al
    Severe asthma in Kuwait population: Phenotype-based approach.
    Respir Med. 2021;187:106586.
    PubMed     Abstract available


  52. CAPSTICK TG, Azeez NF, Deakin G, Goddard A, et al
    Ward based inhaler technique service reduces exacerbations of asthma and COPD.
    Respir Med. 2021;187:106583.
    PubMed     Abstract available


  53. GAGNE M, Lam Shin Cheung J, Kouri A, FitzGerald JM, et al
    A patient decision aid for mild asthma: Navigating a new asthma treatment paradigm.
    Respir Med. 2021 Aug 10:106568. doi: 10.1016/j.rmed.2021.106568.
    PubMed     Abstract available


    July 2021
  54. VEDEL-KROGH S, Nielsen SF, Nordestgaard BG, Lange P, et al
    Asthma and COPD versus phenotypic traits: Toward precision medicine in chronic airway disease.
    Respir Med. 2021;186:106529.
    PubMed     Abstract available


    June 2021
  55. THI LAM H, Van Tuong N, Sy DQ, Lundback B, et al
    Bronchial hyperresponsiveness is common in Hanoi, Vietnam: Asthma probably underdiagnosed.
    Respir Med. 2021;186:106513.
    PubMed     Abstract available


  56. CHAPMAN KR, An L, Bosnic-Anticevich S, Campomanes CM, et al
    Asthma patients' and physicians' perspectives on the burden and management of asthma.
    Respir Med. 2021;186:106524.
    PubMed     Abstract available


  57. SCHYLLERT C, Andersson M, Backman H, Lindberg A, et al
    Childhood onset asthma is associated with lower educational level in young adults - A prospective cohort study.
    Respir Med. 2021;186:106514.
    PubMed     Abstract available


  58. YOUSIF A, Forget A, Beauchesne MF, Lemiere C, et al
    Development of an operational definition of treatment escalation in adults with asthma adapted to healthcare administrative databases: A Delphi study.
    Respir Med. 2021;185:106510.
    PubMed     Abstract available


  59. DUCHENE B, Caffry S, Kaminsky DA, Que LG, et al
    Functional significance of 8-isoprostanes in sinonasal disease and asthma.
    Respir Med. 2021;185:106506.
    PubMed     Abstract available


  60. RODRIGUES AT, Romano S, Romao M, Figueira D, et al
    Effectiveness of a pharmacist-led intervention on inhalation technique for asthma and COPD patients: The INSPIRA pilot cluster-randomized controlled trial.
    Respir Med. 2021;185:106507.
    PubMed     Abstract available


  61. SADEGHDOUST M, Mirsadraee M, Aligolighasemabadi F, Khakzad MR, et al
    Effect of azithromycin on bronchial wall thickness in severe persistent asthma: A double-blind placebo-controlled randomized clinical trial.
    Respir Med. 2021;185:106494.
    PubMed     Abstract available


  62. AL-QEREM WA, Jarab AS
    Applicability of GLI 2012 spirometry equation among preschool aged Jordanian.
    Respir Med. 2021;182:106397.
    PubMed     Abstract available


  63. CRIMI C, Campisi R, Nolasco S, Cacopardo G, et al
    Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study.
    Respir Med. 2021;185:106491.
    PubMed     Abstract available


    May 2021
  64. ANDUJAR-ESPINOSA R, Aparicio-Vicente M, Ruiz-Lopez FJ, Salinero-Gonzalez L, et al
    Influence of vitamin D supplementation on the quality of life of asthma patients: Findings from ACVID randomised clinical trial.
    Respir Med. 2021;185:106484.
    PubMed     Abstract available


  65. LISSPERS K, Stallberg B, Larsson K, Janson C, et al
    Developing a short-term prediction model for asthma exacerbations from Swedish primary care patients' data using machine learning - Based on the ARCTIC study.
    Respir Med. 2021;185:106483.
    PubMed     Abstract available


  66. CORDOVA-RIVERA L, Gardiner PA, Gibson PG, Winkler EAH, et al
    Sedentary time in people with obstructive airway diseases.
    Respir Med. 2021;181:106367.
    PubMed     Abstract available


    April 2021
  67. TIOTIU A, Ioan I, Poussel M, Schweitzer C, et al
    Comparative analysis between available challenge tests in the hyperventilation syndrome.
    Respir Med. 2021;179:106329.
    PubMed     Abstract available


    March 2021
  68. YE L, Gao X, Tu C, Du C, et al
    Comparative analysis of effectiveness of asthma control test-guided treatment versus usual care in patients with asthma from China.
    Respir Med. 2021;182:106382.
    PubMed     Abstract available


  69. CHALITSIOS CV, Shaw DE, McKeever TM
    Corticosteroids and bone health in people with asthma: A systematic review and meta-analysis.
    Respir Med. 2021;181:106374.
    PubMed     Abstract available


  70. KAGOHASHI K, Miyazaki K, Satoh H
    Outcome of SARS-CoV-2 infection in patients with severe asthma on biologics.
    Respir Med. 2021 Mar 6:106358. doi: 10.1016/j.rmed.2021.106358.
    PubMed    


    February 2021
  71. UNNI EJ, Gupta S, Sternbach N
    Using the Medication Adherence Reasons Scale (MAR-Scale) in asthma and chronic obstructive pulmonary disease to determine the extent and identify the reasons for non-adherence.
    Respir Med. 2021;179:106337.
    PubMed     Abstract available


    January 2021
  72. SCOSYREV E, van Zyl-Smit R, Kerstjens H, Gessner C, et al
    Cardiovascular safety of mometasone/indacaterol and mometasone/indacaterol/glycopyrronium once-daily fixed-dose combinations in asthma: pooled analysis of phase 3 trials.
    Respir Med. 2021;180:106311.
    PubMed     Abstract available


  73. ZELL-BARAN LM, Krefft SD, Moore CM, Wolff J, et al
    Multiple breath washout: A noninvasive tool for identifying lung disease in symptomatic military deployers.
    Respir Med. 2021;176:106281.
    PubMed     Abstract available


  74. BJERRUM AS, Skjold T, Schmid JM
    Oral corticosteroid sparing effects of anti-IL5/ anti-IL5 receptor treatment after 2 years of treatment.
    Respir Med. 2021;176:106260.
    PubMed     Abstract available


    November 2020
  75. TERVONEN T, Martinez FJ, Hanania NA, Heidenreich S, et al
    Dual-combination maintenance inhaler preferences in asthma and chronic obstructive pulmonary disease: A patient-centered benefit-risk assessment.
    Respir Med. 2020;176:106278.
    PubMed     Abstract available


  76. PULLERITS T, Ronmark EP, Ekerljung L, Palmqvist MA, et al
    The triad of current asthma, rhinitis and eczema is uncommon among adults: Prevalence, sensitization profiles, and risk factors.
    Respir Med. 2020;176:106250.
    PubMed     Abstract available


  77. KUPCZYK M, Majak P, Kuna P, Asankowicz-Bargiel B, et al
    A new formulation of fluticasone propionate/salmeterol in a metered-dose inhaler (MDI HFA) allows for the reduction of a daily dose of corticosteroid and provides optimal asthma control - A randomized, multi-center, non-inferiority, phase IV clinical
    Respir Med. 2020;176:106274.
    PubMed     Abstract available


  78. BASSAM M, Behbehani N, Farouk H, Alsayed M, et al
    Adherence to medication among adult asthma patients in the Middle East and North Africa: results from the ESMAA study.
    Respir Med. 2020;176:106244.
    PubMed     Abstract available


  79. COTTINI M, Licini A, Lombardi C, Berti A, et al
    Prevalence and features of IOS-defined small airway disease across asthma severities.
    Respir Med. 2020;176:106243.
    PubMed     Abstract available


  80. LOMMATZSCH M, Sauerbeck IS, Wilmer C, Taube C, et al
    Oral corticosteroid prescription for asthma by general practitioners: A three-year analysis in Germany.
    Respir Med. 2020;176:106242.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: